LOPHOS HOLDINGS INC.

Press Releases Lophos Holdings Inc.

Equities

MESC

CA5439371066

Market Closed - Canadian Securities Exchange Other stock markets 12:26:14 2024-05-21 EDT			5-day change	1st Jan Change
0.055 ^CAD	0.00%		+10.00%	+37.50%

04-15	ThreeD Capital Inc. announced that it expects to receive CAD 0.1275 million in funding from Lophos Holdings Inc.	CI
04-15	ThreeD Capital Inc. entered into a securities purchase agreement to acquire 2.5% stake in Lophos Holdings Inc. for CAD 0.05 million.	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lophos Pharmaceuticals Corp. Receives Traditional Blessing for Napanee Site in Honor of Indigenous Heritage	05-15	NE
Lophos Pharmaceuticals Corp. Enters Into Letter of Intent to Acquire the Assets of Magicactus.com	05-06	AQ
Lophos Pharmaceuticals Corp. Commences Peyote Research Protocol	05-02	AQ
Lophos Pharmaceuticals Corp. Expands Peyote Cultivation with the Successful Planting of 3,000 Seeds	04-25	AQ
Lophos Pharmaceuticals’ Licensed Site Celebrates Successful Building Occupancy	04-17	AQ
ThreeD Capital Inc. and Lophos Holdings Inc. Announce Strategic Partnership	04-15	AQ
ThreeD Capital Inc. Announces Securities Purchase Agreement with Lophos Holdings Inc.	04-15	AQ
Lophos Holdings Inc. Celebrates Successful Conclusion of Inaugural Annual General Meeting, Confirms Board Members and Stock Options Plan	03-28	AQ
Lophos Pharmaceuticals Partners With Carmichael Engineering Ltd. for HVAC Project, Anticipates Expedited Building Occupancy	03-05	AQ
Lophos Confirms Appearance at Benzinga Capital Conference in Hollywood, Florida and Finalizes Annual General Meeting	02-28	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Research Protocol for Lophophora Williamsii (Peyote)	02-14	AQ
Lophos Pharmaceuticals Corp. Finalizes the Development of a New Synthetic Mescaline Protocol	02-08	AQ
Lophos Pharmaceuticals Corp. Finalizes Product Release Specifications for Fresh and Dried Peyote (Lophophora williamsii)	01-31	AQ
Health Canada Endorses Lophophora Williamsii, Elevating Lophos Holdings Inc. as a Leader in Natural Health Innovation	01-23	AQ
Lophos Pharmaceuticals Corp. Receives Health Canada Approval for Expanded Controlled Substance Operations Following HVAC Revisions	11-21	AQ
Lophos Secures Game-Changing Controlled Substance Dealer's License with the Expertise of Canalytica Corp.	23-10-10	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer